ACTRN12618001430224
Completed
Phase 2
Efficacy of Botulinum Toxin Type A in the Targeted Treatment of Nocturnal Bruxism: A Double-Blind, Randomised, Placebo-Controlled Cross-over Study
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Melbourne Health
- Enrollment
- 41
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Symptoms of nocturnal bruxism of adequate severity as measured by overnight monitoring.
Exclusion Criteria
- •Contraindication to botulinum toxin administration, concurrent use of medications affecting muscle relaxation, prior history of severe jaw trauma, orofacial pain of an alternate aetiology, neuromuscular disease, major respiratory disease(s) that may preclude overnight EMG recordings, administration of botulinum toxin for other indication (including cosmetic) within 16weeks of study commencement.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Assessment of Botulinum Toxin Type A in the Treatment of Hand EczemaPACTR201704002194318Dermatology Department, Faculty of Medicine, University of Alexandria60
Active, not recruiting
Not Applicable
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166NL-OMON39359Revalidatiecentrum Het Roessingh26
Completed
Not Applicable
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disordersIRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34
Recruiting
Phase 2
Botulinum Toxin Type A with Needle-free Injector System in Palmar HyperhidrosisPalmar hyperhidrosisJPRN-jRCTs041180067Ohshima Yuichiro25